Stockreport

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE [Yahoo! Finance]

CureVac N.V. - Ordinary Shares  (CVAC) 
PDF A hearing on infringement of EP 3 708 668 B1 is scheduled for July 1, 2025, before the Regional Court Düsseldorf Confirming validity of patent in its amended for [Read more]